Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating induction and tapering therapy with tofacitinib in combination with glucocorticoids for polymyalgia rheumatica. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucocorticoid (glucocorticoid)
  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Zhejiang University | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: RECRUITING